LifeVantage Preliminary Revenue Up 17% To $58 Million For Q2

LifeVantage Corporation (Nasdaq:LFVN) today announced preliminary revenue for the fiscal 2019 second quarter and six month period ended December 31, 2018.

Preliminary revenue for the second quarter of fiscal 2019 increased approximately 17% to $58 million, compared to $50 million in the prior year period. Preliminary revenue for the first six months of fiscal 2019 increased approximately 15% to $114 million compared to $99 million in the prior year period.

“We are proud to report the highest level of quarterly revenue in the Company’s history,”

stated LifeVantage President and Chief Executive Officer Darren Jensen.

“The second quarter strength reflected a strong response to the launch of our TrueScience Hair Care System and broad based growth across our global footprint, particularly in Taiwan and the United States, reflecting the success of our 2019 initiatives.”

The Company is releasing preliminary second quarter fiscal 2019 revenue in advance of its participation and presentation at the ICR Conference on January 14-16, 2019.

The Company does not intend to release preliminary quarterly revenue in the future.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in Nutrigenomics – a new science dedicated to biohacking the human aging code.

The company is engaged in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin and hair care products, including Protandim®, a line of scientifically-validated dietary supplements;

TrueScience®, a line of Nrf2 infused skin care and hair care products; Petandim™ for Dogs, a companion pet supplement formulated to combat oxidative stress in dogs; Axio® Smart Energy Drink mixes; PhysIQ™, a Smart Weight Management System; and Omega+, a 3-in-1 fish oil supplement. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah.

For more information, visit www.lifevantage.com